Hua Chen

Summary

Country: China

Publications

  1. doi Growth inhibitory effects of dihydroartemisinin on pancreatic cancer cells: involvement of cell cycle arrest and inactivation of nuclear factor-kappaB
    Hua Chen
    Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Harbin Medical University, 23 Youzheng Street, Nangang District, 150001 Harbin, China
    J Cancer Res Clin Oncol 136:897-903. 2010
  2. ncbi [Study on anticancer effect of dihydroartemisinin on pancreatic cancer]
    Hua Chen
    Department of Hepatobiliary and Pancreatic Surgery, The First Clinical College of Harbin Medical University, Harbin 150001, China
    Zhonghua Wai Ke Za Zhi 47:1002-5. 2009
  3. ncbi [Experimental study of the function and mechanism combining dihydroartemisinin and gemcitabine in treating pancreatic cancer]
    Shuang Jia Wang
    Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China
    Zhonghua Wai Ke Za Zhi 48:530-4. 2010
  4. doi Downregulation of nuclear factor-kappaB p65 subunit by small interfering RNA synergizes with gemcitabine to inhibit the growth of pancreatic cancer
    Rui Kong
    The Hepatosplenic Surgery Center, Department of General Surgery, The First Affiliated Hospital of Harbin Medical University, China
    Cancer Lett 291:90-8. 2010
  5. doi The strategy of combined ischemia preconditioning and salvianolic acid-B pretreatment to prevent hepatic ischemia-reperfusion injury in rats
    Rui Kong
    Department of Hepatobiliary and Pancreatic Surgery, The First Clinical College of Harbin Medical University, You Zheng Street 23, Harbin, China
    Dig Dis Sci 54:2568-76. 2009
  6. doi Dihydroartemisinin inactivates NF-kappaB and potentiates the anti-tumor effect of gemcitabine on pancreatic cancer both in vitro and in vivo
    Shuang Jia Wang
    Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, PR China
    Cancer Lett 293:99-108. 2010

Collaborators

Detail Information

Publications6

  1. doi Growth inhibitory effects of dihydroartemisinin on pancreatic cancer cells: involvement of cell cycle arrest and inactivation of nuclear factor-kappaB
    Hua Chen
    Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Harbin Medical University, 23 Youzheng Street, Nangang District, 150001 Harbin, China
    J Cancer Res Clin Oncol 136:897-903. 2010
    ....
  2. ncbi [Study on anticancer effect of dihydroartemisinin on pancreatic cancer]
    Hua Chen
    Department of Hepatobiliary and Pancreatic Surgery, The First Clinical College of Harbin Medical University, Harbin 150001, China
    Zhonghua Wai Ke Za Zhi 47:1002-5. 2009
    ..To investigate the anti-tumor activity of dihydroartemisinin in pancreatic cancer in vitro and in vivo...
  3. ncbi [Experimental study of the function and mechanism combining dihydroartemisinin and gemcitabine in treating pancreatic cancer]
    Shuang Jia Wang
    Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China
    Zhonghua Wai Ke Za Zhi 48:530-4. 2010
    ..To investigate the anti-tumor activity of combined gemcitabine with dihydroartemisinin, and the mechanism of the anti-tumor effect of gemcitabine enhanced by dihydroartemisinin on pancreatic cancer...
  4. doi Downregulation of nuclear factor-kappaB p65 subunit by small interfering RNA synergizes with gemcitabine to inhibit the growth of pancreatic cancer
    Rui Kong
    The Hepatosplenic Surgery Center, Department of General Surgery, The First Affiliated Hospital of Harbin Medical University, China
    Cancer Lett 291:90-8. 2010
    ..The results suggest that downregulation of NF-kappaB p65 potentiates the efficacy of gemcitabine in combating pancreatic cancer...
  5. doi The strategy of combined ischemia preconditioning and salvianolic acid-B pretreatment to prevent hepatic ischemia-reperfusion injury in rats
    Rui Kong
    Department of Hepatobiliary and Pancreatic Surgery, The First Clinical College of Harbin Medical University, You Zheng Street 23, Harbin, China
    Dig Dis Sci 54:2568-76. 2009
    ..The aim of this study was to evaluate the protective effect of combined ischemic preconditioning (IPC) and salvianolic acid-B (Sal-B) pretreatment against IRI-induced hepatocellular injury...
  6. doi Dihydroartemisinin inactivates NF-kappaB and potentiates the anti-tumor effect of gemcitabine on pancreatic cancer both in vitro and in vivo
    Shuang Jia Wang
    Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, PR China
    Cancer Lett 293:99-108. 2010
    ..We concluded that inhibition of gemcitabine-induced NF-kappaB activation is one of the mechanisms that DHA dramatically promotes its anti-tumor effect on pancreatic cancer...